Organization
La Paz University Hospital, Department of Rheumatology, IdiPaz, Madrid, Spain
1 abstract
Abstract
BIMEKIZUMAB MAINTAINED STRINGENT CLINICAL RESPONSES THROUGH WEEK 52 IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE PHASE 3 STUDIES BE MOBILE 1 AND BE MOBILE 2Org: Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Berlin, Germany, Leiden University Medical Center, Department of Rheumatology, Leiden, Netherlands, Ruhr-University Bochum, Rheumazentrum Ruhrgebiet Herne, Bochum, Germany, Brigham and Women’s Hospital and Harvard Medical School, Division of Rheumatology, Inflammation and Immunity, Boston, Massachusetts, United States of America, UCB Pharma, N/A, Brussels, Belgium,